IL17D and neoplasm: Taking into account the propensity of IL-17A to propel tumor growth either in an autocrine (61, 166) or paracrine fashion (37), findings on IL-17D suggest that this cytokine counterbalances the pro-tumor activity of Th17 cells and IL-17A, and strategies to increase IL-17D might find clinical application.